GWM
IONS icon

Gilpin Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Gilpin Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$45 Buy
+1
New +$57 ﹤0.01% 1399

Other funds holding IONS

WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

Gilpin Wealth Management's IONS Position: Q3 2026 in Review

Gilpin Wealth Management opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 1 share worth $45. The stake represents ﹤0.01% of the portfolio and ranks #1399 among its holdings.

11 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Gilpin Wealth Management held 1 share of Ionis Pharmaceuticals worth $45 as of Q3 2026.
  • Ionis Pharmaceuticals was a new Gilpin Wealth Management position in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1399 holding.
  • 11 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.